[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100585845":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":54,"collaborators":56,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":56,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":77,"overallStatus":38,"whyStopped":56,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Nice","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Morning injection","ACTIVE_COMPARATOR","VAXIGRIPTETRA influenza vaccine injection between 07:00 am and 11:00 am.",[13],"Other: Vaccine injection",{"label":15,"type":10,"description":16,"interventionNames":17},"Evening injection","VAXIGRIPTETRA influenza vaccine injection between 05:00 pm and 09:00 pm.",[13],[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":23},"Vaccine injection","Injection of the vaccine in chronic renal insufficiency patients.",[15,9],[24],"VAXIGRIPTETRA - quadrivalent inactivated influenza vaccine.",[26],{"name":27,"affiliation":5,"role":28},"GOSSET Clément, MD","PRINCIPAL_INVESTIGATOR",[30],{"name":27,"role":31,"phone":32,"phoneExt":33,"email":34},"CONTACT","492038632","+33","gosset.c@chu-nice.fr",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"CHU Nice - Hôpital Pasteur 2","RECRUITING","Nice","Alpes-Maritimes","06000","France","FR",{"type":45,"coordinates":46},"Point",[47,48],7.26608,43.70313,{"lat":48,"lon":47},[51],{"name":52,"role":31,"phone":53,"phoneExt":33,"email":34},"Clément GOSSET, MD","492037918",{"type":55,"investigatorFullName":56,"investigatorTitle":56,"investigatorAffiliation":56,"oldNameTitle":56,"oldOrganization":56},"SPONSOR",null,"100585845","study-of-the-impact-of-time-of-vaccination-on-response-to-influenza-vaccine-in-patients-with-chronic-renal-failure-100585845",false,"NCT06907667","Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure","Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure - CHRONOVAX 2","CHRONOVAX2","Inclusion Criteria:\n\n* Chronic renal failure patient at stage 4 or 5 (i.e. estimated GFR \\\u003C 30mL\u002Fmin\u002F1.73m2); or Dialysis patient; or renal transplant patient regardless of GFR;\n* Age ≥ 18 years;\n* Indication for influenza vaccination;\n* Express free and informed consent.\n\nExclusion Criteria:\n\n* Known hypersensitivity to influenza vaccine or egg proteins;\n* Previous influenza vaccination for the current season;\n* Current infection;\n* Current acute illness;\n* Treatments with a major impact on vaccine response:\n* Treatment of rejection within the previous 3 months;\n* Renal transplantation with induction performed within the previous 6 months;\n* Immunosuppressive treatment including CTLA4 agonist, complement inhibitor, anti-CD20;\n* Treatments that may distort the serological response: Polyvalent immunoglobulin infusion within the preceding 3 months;\n* Vulnerable persons (minors, adults under guardianship or trusteeship, persons deprived of their liberty, persons unable to speak French);\n* Subjects not affiliated to Social Security.","ALL","18 Years","100 Years",{"count":69,"type":70},735,"ESTIMATED","INTERVENTIONAL",[73],"NA","Immune response to influenza vaccine in patients with chronic renal insufficiency.",[76],"Vaccination; Infection",[78,79,80],"Influenza","chronic renal insufficiency","Vaccination","2026-05-13",{"date":83,"type":84},"2026-05-15","ACTUAL",{"date":86,"type":84},"2025-09-03",{"date":88,"type":70},"2027-09",{"name":5,"class":6},1]